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Abstract
Schistosomiasis is one of the major Neglected Tropical Diseases (NTDs) in sub-Saharan
Africa. In sub-Saharan Africa, two major human schistosome species namely Schistosoma
mansoni and S. haematobium often occur sympatrically largely affecting children. Recogniz-
ing the public health impact of Schistosomiasis, the World Health Organization (WHO) is
urging member states to regularly treat at least 75% and up to 100%, of all school-aged chil-
dren at risk of morbidity. For control strategies based on targeted mass drug administration
(MDA) to succeed it is essential to have a simple and sensitive test for monitoring the suc-
cess of these interventions. Current available diagnostic tests, such as egg detection in stool
by Kato-Katz (KK) for S. mansoni and detection of eggs or blood (hematuria) in urine for S.
haematobium have reduced sensitivity in low intensity settings. The objective of the study
was to evaluate active single or duo schistosome infections in school children following MDA
using molecular diagnostics (PCR) on filtered urine samples and comparing that against tra-
ditional diagnostic tests. This cross-sectional study was conducted among 111 school chil-
dren aged 7–15 years in Chongwe and Siavonga Districts in Zambia. Species-specific cell-
free repeat DNA fragment were amplified from 111 filtered urine samples. Our approach
detected eight times more positive cases (total 77) than by KK (9) for S. mansoni and six
times more (total 72) than by hematuria (11) for S. haematobium and even more against
urine filtration (77 compared to only 6). The same pattern was observed when stratified for
age group and sex specific analysis with 100% sensitivity and specificity devoid of any cross
amplification. In addition, 69 individuals (62%) were co-infected by both parasites. We have
demonstrated a significantly higher prevalence of both species than indicated by the tradi-
tional tests and the persistent maintenance of reservoir of infection after MDA. Our approach
is an effective means of detecting low intensity infection, which will enhance the effectiveness
of surveillance and assess the impact of MDA control programs against schistosomiasis.







Citation: Hessler MJ, Cyrs A, Krenzke SC,
Mahmoud ES, Sikasunge C, Mwansa J, et al.
(2017) Detection of duo-schistosome infection
from filtered urine samples from school children in
Zambia after MDA. PLoS ONE 12(12): e0189400.
https://doi.org/10.1371/journal.pone.0189400
Editor: Matty Knight, George Washington
University School of Medicine and Health Sciences,
UNITED STATES
Received: August 11, 2017
Accepted: November 26, 2017
Published: December 11, 2017
Copyright: © 2017 Hessler et al. This is an open
access article distributed under the terms of the
Creative Commons Attribution License, which
permits unrestricted use, distribution, and
reproduction in any medium, provided the original
author and source are credited.
Data Availability Statement: All relevant data are
within the paper and its Supporting Information
file.
Funding: NL received an Early Career Research
award from Thrasher Research Fund. The study
was possible because of this funding. The
Foundation had no role in designing or
conceptualization of the study. https://www.
thrasherresearch.org/default.aspx.
Competing interests: No competing interests.
Introduction
Schistosomiasis in Africa is an ongoing public health problem, which in recent times has
attracted a major campaign to control the disease. In 2014, approximately 91% of people esti-
mated to require treatment for schistosomiasis lived in the African region [1]. Children are
particularly vulnerable to schistosome infections and are likely to be the main carriers of infec-
tion due to their large egg output and increased water contact [2]. Recognizing the public
health impact of schistosomiasis on school-age children, the World Health Organization
(WHO) is urging member states to regularly treat at least 75% and up to 100%, of all school-
aged children at risk of morbidity [3]. Forty three million school-age children received treat-
ment in 2014 comprising >83% of the total number of people treated [1]. As the control pro-
grams become more and more effective in reducing the parasite burden in children, the issue
of diagnostic sensitivity will become more critical in the assessment of program effectiveness.
It is important to determine if these children can still infect snails (vector) and keep the trans-
mission going. For mass drug administration (MDA) to succeed, these reservoirs of infection
must be diagnosed and the diagnostic method to do so should be one that is easy to operate,
sensitive and accurate.
The diagnostic problem for schistosomiasis is exacerbated by the fact that in Africa, the
two-parasite species, Schistosoma mansoni and S. haematobium are often sympatric and con-
current infection is debilitating [4]. Because different organ systems are involved, the patho-
logical implications of single or mixed infections are different, it is therefore important to
differentiate accurately between them. Present clinical studies are often unable to detect light
infections as well as sympatric, multiple parasite infection due to lack of sensitivity and speci-
ficity of current parasitological and proposed point of care (POC) techniques [5]. Searching
for parasite eggs in light intensity infections is difficult and more often than not, such infec-
tions are misdiagnosed [6].
Current available diagnostic tools, such as egg detection in stool by Kato-Katz (KK) for S.
mansoni and detection of eggs or blood (hematuria) in urine for S. haematobium lack sensitiv-
ity in low intensity settings [5, 7, 8]. Our previous work successfully detected schistosome spe-
cific DNA in S. mansoni [8] and S. haematobium [7] from filtered urine using polymerase
chain reaction (PCR) with high sensitivity (true positive) and specificity (true negative) with
no cross-reactivity with other related parasites. We also demonstrated that it is possible to
detect DNA specific to both of these two schistosome parasites from a single source of urine,
thus simplifying the collection and performance of tests that are more sensitive and more spe-
cific than the standard diagnostic tests [9]. It is important to note that the presence of DNA in
urine indicates a viable infection. The test is superior in sensitivity and specificity to KK and
hematuria [7–9].
Our recently developed diagnostic test targets mass treatment program and thus addresses
the issues of sensitivity and specificity. It also addresses logistical problems associated with
sample collection and handling in situations where stool samples are needed. To evaluate the
control or intervention programs, more sensitive and specific tests need to be introduced. We
reiterate here as campaigns progress, infections become less severe and the tests will become
less effective, missing detection of asymptomatic carriers who are the source of continued
transmission. To address this, we tested our diagnostic technique in Zambia in an on-going
schistosomiasis control intervention (mass and targeted chemotherapy distributed through
schools). Therefore, a method was devised that avoids working with fecal samples in the detec-
tion of S. mansoni infections in school going children in two of the Schistosomiasis endemic
districts (Chongwe and Siavonga) in Zambia. Hence the purpose of this study was to evaluate
active single or duo schistosome infection in school children after MDA with highly sensitive
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and specific species-specific repeat DNA detection from filtered urine samples and comparing
that against traditional diagnostic tests.
Materials and methods
Study design and sample population
A cross-sectional study was conducted in two districts, namely, Chongwe district in Lusaka
Province and Siavonga district in Southern Province. Chongwe district is located near the
highly meandering Chongwe River while Siavonga district is along the shores of Lake Kariba.
These study districts were selected based on previous mapping results, which indicated
endemicity for both schistosome species. The selected districts thus were and are part of the
on-going annual MDA and general infection on intensity was therefore expected to be low.
The study population was comprised of 111 school going children aged 7–15 years old (60
female and 50 male students; Table 1). For one children, the sex was not recorded, but was
included in the analysis (S1 Data). Participants were recruited in July 2016, one (1) month
after MDA with praziquantel given at 40mg/kg. Samples were collected from participants after
obtaining written informed consent from parents or guardians and a verbal assent from
minors. As this was a cross sectional study, there were no drop outs.
Data (sample) collection
All participants provided both urine and stool samples after the purpose of the study was
explained to them and consent obtained. Urine specimens were collected in plastic cups, and
then numbered and referenced across all filtered urine samples. Each student volunteer was
then provided with a second cup for stool. The same reference number was used for all speci-
mens from a single volunteer. The number assigned to the volunteer was transferred on the fil-
ter paper prior to urine filtration. The information that was made available to the researcher in
the USA was only age, sex and locality of each sample. All personal reference was secured and
retained in Zambia. The study was approved by institutional review board (IRB) of Marquette
University, USA (IRB # HR-3116) and by ERES Converge, Zambia (IRB # 2016-Apr-002).
Parasitological tests
Stool samples were processed and examined for presence of S. mansoni egg by using WHO
standard KK kit (WHO, Geneva, Switzerland). Two stool smears per sample were examined
by KK [10]. All urine samples were tested for hematuria for S. haematobium by Multistix (Sie-
mens Healthcare Diagnostics Inc., Tarrytown, NY, USA) and urine filtration (Sterlitech,
Washington, USA) for presence of S. haematobium eggs. In addition, 40 ml of urine were fil-
tered through Whatman # 3 filter paper, air dried and then packed individually in Ziploc bags
shipped to Milwaukee, Wisconsin USA. This was a research project and the technique is
intended to be introduced in country with subsequent proposals and recommended to the
National control program.
Table 1. Demographic characteristics of the study population.
Age group
Sex 7–12 years 13–15 years Total
Male 31 19 50
Female 44 16 60
Total 75 35 110¶
https://doi.org/10.1371/journal.pone.0189400.t001
Multi schistosome detection after MDA
PLOS ONE | https://doi.org/10.1371/journal.pone.0189400 December 11, 2017 3 / 12
DNA extraction from filtered urine
DNA from filtered urine samples were extracted by QIAmp DNeasy1 Blood and Tissue Kit
(Qiagen, Hilden, Germany). The filter paper quadrant used for draining the urine was used to
punch 15 holes (~1mm diameter) by regular paper punch. The paper punch and scissor was
sterilized by washing with 10% bleach and nuclease-free-water after every use for minimizing
any chance of contamination [9]. The paper discs were added to nuclease-free-water in 2 ml
Eppendorf tubes. These were then heat shocked at 95˚C for 10 minutes. After heat shock, the
tubes were left on a shaker at 150 rpm for overnight.
The next morning, tubes were removed from the shaker and centrifuged at 8,000 x g for 1
minute. The liquid in tube was transferred into a QIAmp 2 ml column tube. Then DNA was
extracted according to the manufacturer’s protocol. All extracted DNA was quantified by
using Nanodrop (Thermo Scientific, Wilmington, DE, USA) to determine the concentration
of the extracted DNA after which all the extracts were stored at -20˚C until use.
PCR amplification of schistosome species
Species-specific primers [9] were used (Table 2) to amplify cell-free repeat DNA fragments from
filtered urine samples to confirm the presence of either S. mansoni or S. haematobium or both.
For every reaction, three different controls were used: 1) S. mansoni and S. haematobium geno-
mic DNA (BEI Resources, Manassas, VA, USA) as positive control; 2) extracted DNA from
urine collected in-house as negative control; and 3) nuclease-free-water as water control
(Sigma-Aldrich, St. Louis, MO, USA). A commercially purchased Mastermix (New England
Biolabs, Ipswich, MA, USA), 10μM forward and reverse primers, magnesium, and nuclease-
free-water (Sigma-Aldrich, St. Louis, MO, USA) was used for a 20μl PCR reaction. PCR amplifi-
cation took place in an automated thermocycler with the following settings. For amplification of
S. mansoni, the denaturation at 95˚C for 10 minutes was followed by annealing process of 57˚C
for 90 seconds, which was repeated 35 times and ended with an extension at 72˚C for 10 min-
utes. For the amplification of S. haematobium, the steps were same for denaturation expect that
the annealing process was set at 56˚C for 90 seconds and final extension of 72˚C for 1 minute.
Statistical analyses
The sensitivity and specificity of PCR amplification for both species were compared against
KK, urine filtration and hematuria using MedCalc 12.4.0 (MedCalc Software, Ostend, Bel-
gium). The data was also stratified for two different age groups (Group A: 7–12 years and
Group B: 13-15yeras) and sex (female and male) for determining the efficacy of different diag-
nostic approaches. Results were converted to numerical values (1 = positive and 0 = negative)
for performing the statistical analysis. The positive and negative assessment of each sample
was based on following predictions.
Table 2. Primer sets used for species-specific cell-free repeat DNA amplification of Schistosoma mansoni and S. haematobium by PCR method.
Schistosome parasite Oligonucleotide name Oligonucleotide sequence Reference
Schistosoma mansoni SmPF 5' GAT CTG AAT CCG ACC AAC CG 3' Lodh et al., 2014
SmPR 5' ATA TTA ACG CCC ACG CTC TC 3'
Schistosoma haematobium ShDra1F 50 TCA CAA CGA TAC GAC CAA C 30 Lodh et al., 2014
ShDra1R 50 GAT CTC ACC TAT CAG ACG AAA C 30
After amplification, gel electrophoresis was run to visualize the amplified species-specific DNA fragments. A 2% agarose gel stained with SYBR Green
(Thermo Scientific, Waltham, MA, USA) was used. A 50bp reference ladder (New England Biolabs, Ipswich, MA, USA) was used for size comparison of
amplified fragment. All agarose gels were visualized in Azure C200 gel documentation system (Azure Biosystems, Dublin, CA, USA).
https://doi.org/10.1371/journal.pone.0189400.t002
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• If KK +, then sure presence of S. mansoni infection
• If S. mansoni PCR +, then assume presence of S. mansoni infection
• S. mansoni True Positive (TP): If KK + and S. mansoni PCR +
• S. mansoni True Negative (TN): If KK − and S. mansoni PCR −
• If urine filtration +, then sure presence of S. haematobium infection
• If S. haematobium PCR +, then assume presence of S. haematobium infection
• S. haematobium True Positive (TP): If urine filtration + and S. haematobium PCR +
• S. haematobium True Negative (TN): If urine filtration − and S. haematobium PCR −
Disease prevalence was calculated based on number of positive cases by each diagnostic test
against the total number of samples were evaluated. Agreement statistics were calculated by
measuring Kappa value and Bowker’s Symmetry by JMP 12 (JMP1 v12, SAS Institute Inc.,
Cary, North Carolina, USA) to establish the agreement between two diagnostic tests. Kappa
coefficient range (-1–0 –+1) determined the agreement between two tests, where +1 = complete
agreement, 0 = marginal agreement and -1 = no agreement. Bowker’s symmetry determined
the lack of agreement (JMP1 v9, SAS Institute Inc., Cary, North Carolina) between two tests
at a time. This test checked for symmetry in 2-way tables and the test decision was based on X2
approximation of the distribution of the test statistic [11].
Results
Detection of Schistosoma mansoni by KK and PCR
The purpose of this research was to determine the effectiveness of detecting small amount of
parasite repeat DNA fragments in urine samples from school children infected with S. mansoni
or S. haematobium, or both after MDA (Fig 1). Conventional PCR performed in the laboratory
Fig 1. Agarose gel image of the repeat fragment amplicons for both S. mansoni and S. haematobium with
species-specific primers.
https://doi.org/10.1371/journal.pone.0189400.g001
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was compared to detection methods used in the field, such as KK for stool samples and hema-
turia and urine filtration for urine examination.
The comparison of KK and PCR in the detection of S. mansoni infection was most notably
distinguished when dealing with low-level infections (no egg is found in the stool sample) and
asymptomatic infections. Of the 111 samples that were tested, only 9 were positive by both KK
and PCR, whereas 77 were positive by PCR (Table 3). Overall 25 were negative by both KK
and PCR (Table 3). There were no false positives produced by either method. PCR was the bet-
ter indicator of disease prevalence (78% vs. 8%; Table 4). With a sensitivity of 100% compared
to only 11% for KK (Table 4). The implication of negative infection due to KK test [Negative
Predictive Value (NPV): 25%, Table 4] was a great underestimate of actual number of school
children that were infected or had retained infection (NPV: 100%; Table 4). A significantly low
level of agreement was detected between KK and PCR (Kappa = 0.05; 95% CI: 0.01–0.09;
Table 5). The Bowker Symmetry was significantly different from random for the comparison,
indicating that PCR will detect more positive infection than the ones positive by KK due to its
higher sensitivity (Table 5).
Table 3. The comparison of diagnostic evaluation of 111 field collected stool and urine samples for
both Schistosoma mansoni and S. haematobium. S. mansoni egg presence in stool was evaluated by
Kato-Katz (KK) and S. haematobium was evaluated by measuring hematuria (sign of blood) and by
urine filtration for egg presence in urine. The filtered urine samples were evaluated for presence of both
species by amplifying species-specific repeat DNA fragment.
Schistosoma mansoni
N = 111 samples evaluated KK negative KK positive
Urine PCR negative 25 (23%) 0
Urine PCR positive 77 (69%) 9 (8%)
Schistosoma haematobium
N = 111 samples evaluated Hematuria negative Hematuria positive
Urine PCR negative 28 (25%) 0
Urine PCR positive 72 (65%) 11 (10%)
N = 111 samples evaluated Urine filtration negative Urine filtration positive
Urine PCR negative 28 (25%) 0
Urine PCR positive 77 (69.5%) 6 (5.5%)
https://doi.org/10.1371/journal.pone.0189400.t003
Table 4. Qualitative analysis to determine disease prevalence, sensitivity, specificity, and predictive values of Kato-Katz (KK), hematuria, urine fil-












KK for S. mansoni 8% 11% (5%–19%) 100% (86%–
100%)
100% 25%







10% 13% (7%–23%) 100% (88%–
100%)
100% 28%
Urine filtration for S.
haematobium
5% 7% (3%–15%) 100% (88%–
100%)
100% 27%





*Disease prevalence = proportion of positive infection by each test out of total number of samples were evaluated
https://doi.org/10.1371/journal.pone.0189400.t004
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Detection of Schistosoma haematobium by hematuria, urine filtration
and PCR
In the field, dipstick (to detect hematuria) and urine filtration (to detect S. haematobium egg)
were used to determine the presence of S. haematobium infection. A PCR was performed to
amplify the S. haematobium specific DNA from filtered urine sample. Again, PCR was the best
method for detecting S. haematobium infection. Hematuria exhibited far more false negative
(FN) cases (72) than PCR (none: Table 3). There were 28 samples negative by both hematuria
and PCR, and 11 samples were positive by both methods (Table 3). This was expected as hema-
turia is a non-specific indicator of S. haematobium infection. Urine filtration yielded even
more FN (77) than hematuria did (Table 3) compared to PCR (none). Also, PCR was the best
method 100% sensitive compared to hematuria (13%) and urine filtration (7%; Table 4). The
Kappa agreement statistics indicated that PCR performed significantly better in detecting S.
haematobium infections than hematuria (Kappa = 0.07; 95% CI: 0.02–0.19; Table 5). The sym-
metry of disagreement was also significantly higher (72; P = 0.0001), which indicated that PCR
scored more positives, especially when infection was asymptomatic and cannot be determined
by hematuria (Table 4). Similarly, there was a significant low degree of agreement between
urine filtration and PCR (Kappa = 0.04; 95% CI: 0.01–0.07; Table 5). The Bowker’s symmetry
was higher when comparing these two methods (77; P = 0.0001; Table 5).
Duo species detection by parasitological and molecular diagnostic assay
This study found school children infected with both schistosome species detected from
extracted DNA from a single urine specimen. A total of 69 children out of 111 children evalu-
ated were found to have mixed infection. The mixed infection was comparatively much higher
for PCR detection of both S. mansoni and S. haematobium (62%) than KK, hematuria and
urine filtration combined (Table 6). Single infection for S. mansoni was at 17 by PCR whereas
KK detected only 7. For S. haematobium it was 14 by PCR and only 9 and 4 by hematuria and
urine filtration, respectively (Table 6). An unexpectedly four times more children who did not
show any signs of being infected using parasitological methods came out positive for both spe-
cies by species-specific repeat DNA detection (Table 6).
Age and gender-specific detection
All the above-mentioned tests were evaluated for both female and male participants and for
two age groups (Group A: 7–12 years and Group B: 13–15 years). PCR proved to be the best
Table 5. Agreement statistics estimation (Kappa coefficient and Bowker symmetry test) comparing species-specific DNA amplification method
for both Schistosome species against Kato-Katz (KK), hematuria and urine filtration.
Comparison of diagnostic tests Kappa coefficient Bowker’s symmetry test$
Degree of agreement 95% CI Symmetry of disagreement P valueψ
Schistosoma mansoni 0.05 0.01–0.09 77 0.0001*
KK vs. urine PCR
Schistosoma haematobium
Hematuria vs. urine PCR
0.07 0.02–0.19 72 0.0001*
Urine filtration vs. urine PCR 0.04 0.01–0.07 77 0.0001*
$Bowker’s Symmetry test = this test checks for symmetry in 2-way tables and the test decision is based on a X2 approximation of the distribution of the test
statistic
ψ
= α level was set at 0.05
* = Significant
https://doi.org/10.1371/journal.pone.0189400.t005
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indicator of positive infection in female participants for both pre-teen and teen-age groups at
70% and 87%, respectively when compared for mixed infection (Fig 2). The same outcome was
also evident for male school children with both age groups 74% and 74% (Fig 2). Parasite DNA
detection effectively identified positive infection irrespective of sex and age.
Discussion
We have demonstrated a significantly higher prevalence of S. mansoni or S. haematobium and/
or both in school children than indicated by the classical examination of urine or stool after
MDA. Our findings have shown that detection of cell-free repeat DNA via PCR is at least six to
eight times more sensitive than any of the parasitological methods, KK, hematuria and urine
filtration. It can be seen clearly from our results that after MDA, use of hematuria and egg
detection missed the detection of the actual S. haematobium infections. Definitive tests have
depended on detecting parasite eggs in the urine and stool, but with low intensity infections
especially after MDA these tests have been shown to have low sensitivity. This is prominently
evident by our current findings (Table 4). More interestingly, the revelation of 62% of school
children with mixed infection (Table 6) after treatment indicates the distribution of both spe-
cies and their snail host, as the pathogenicity and disease outcome is significantly different for
S. mansoni and S. haematobium [12]. Our findings have shown that PCR can detect a true posi-
tive or a true negative even when the infection load is lower as may be the case after MDA.
With drug treatment, infections become less severe and the traditional tests will become less
effective, missing detection of asymptomatic carriers who might be the source of continued
transmission [13]. Highly sensitive species-specific DNA detection via PCR is beneficial,
because if the schistosomes can be more accurately diagnosed, then the drug that treats schis-
tosomiasis, Praziquantel (PZQ), can be used more efficiently in order to prevent any future
drug resistance.
The drug PZQ is unique. It is the only drug that effectively treats the three-major human
schistosomes including S. japonicum [14–16]. PZQ is a widely used drug against schistosome
species and its usage is likely to grow in the near future [17]. Although there is no clinically
relevant evidence of PZQ resistance [17], but it still remains a threat. So, it would be wise to
consider adequate monitoring of current MDA programs. It is important to decipher the fre-
quency of re-infection and remaining infection after treatment [18]. The long-term success of
MDA is dependent on the ability of health authorities to diagnose persistent low intensity
infections that persist even after treatment has occurred [19]. People with low parasitaemia
still pass viable schistosome eggs out in the urine and stool and the hatching miracidia are effi-
cient in locating the intermediate host snails [20] and maintaining the cycle. International
agencies are now attempting to introduce targeted therapy in many, resource poor areas in
Table 6. Detection of single or mixed S. mansoni and S. haematobium infection by KK, hematuria, urine filtration and PCR. Test specific for each
species has been mentioned.
Diagnostic tests Single infection (by only one test) Mixed infection (by both species¶) Total # of infection
KK (S. mansoni) 7 2 (2%) 102
Hematuria (S. haematobium) 9 2 (2%) 100
Urine filtration (S. haematobium) 4 2 (2%) 105
S. mansoni PCR 17 69 (62%) 25
S. haematobium PCR 14 69 (62%) 28
¶
= by KK and hematuria or by KK and urine filtration or by all three tests.
https://doi.org/10.1371/journal.pone.0189400.t006
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Africa where schistosomiasis is prevalent [21]. The main problem in sustaining these efforts is
with the diagnostic tests available to detect infection. Thus, with re-infection and persistent
infection in children when treatment is only partially effective, many infected individuals usu-
ally remain with undiagnosed infection. Therefore, sensitive and accurate tests such as the one
used in this study that can be used to detect for both sympatric species from one sample across
different age group and irrespective of gender are urgently needed (Fig 1).
Detection of parasite specific DNA in urine or bodily fluids indicates the presence of the
actual parasite even when eggs are not always detectable [22]. We have successfully detected
schistosome specific DNA in S. haematobium [7] and S. mansoni [8] from filtered urine and
always showed high sensitivity and specificity with no cross-reactivity with other related hel-
minths. We have also demonstrated that it is possible to detect DNA specific to both schisto-
some parasites from a single source of urine, thus simplifying the collection and performance
of tests that are more sensitive and more specific than the standard diagnostic tests [9]. Our
Fig 2. Detection of dual infection (both S. mansoni and S. haematobium) by species-specific repeat DNA amplification from single
urine sample. The dual infection for both species is categorized into two different age groups (Group A: 7–12 years and Group B: 13–15
years) and for both female and male participants.
https://doi.org/10.1371/journal.pone.0189400.g002
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current findings were consistent with our previous findings and would be more useful for tar-
geted therapy and a successful control intervention.
We acknowledge however, the limitations of the small sample size used in our study to
demonstrate the efficacy of different diagnostic tests after drug treatment. A large sample size
coupled with the use of other tests, such as the Circulating Cathodic Antigen test (CCA) for S.
mansoni and Circulating Anodic Antigen test (CAA) for S. haematobium would probably have
given a more informative or explanatory result. The usage of PCR as a diagnostic test also has
technical limitation. PCR amplification requires the use of a thermocycler for amplification
and electrophoresis equipment for visualization. These are difficult to implement in resource
constraint areas and under field conditions. The need for the equipment can be replaced in the
field using loop-mediated isothermal amplification (LAMP) [23] or recombinase polymerase
amplification (RPA) [24]. LAMP procedure uses three sets of primers to amplify six regions of
the target DNA. Amplification of the DNA occurs independently of a thermocycler, and will
change turbidity if the reaction is positive [25]. While the concept of adapting DNA amplifica-
tion-based diagnosis/monitoring to field laboratories in Africa will likely require a quantum
leap in diagnostic facilities, its initial establishment may benefit from sophistication.
Therefore, if this species-specific PCR was to be developed in a LAMP form, it would make
this diagnostic technique more affordable, quick, specific and simple to use even in the field.
This can be used as an integrated part of surveillance program to measure the effectiveness of
control intervention. Innovative diagnostic tools for the “end-game” of control interventions are
warranted in the control of schistosomiasis and PCR and LAMP based methods cannot be ruled
out. Our study has demonstrated that without stool examination, urine filtered through filter
papers could be used to concurrently diagnose both S. mansoni and S. haematobium species.
Supporting information
S1 Data. Data for all 111 samples that has been used in the study.
(XLSX)
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